Herbalife Q4 earnings, revenue beat; stock rises

Herbalife Ltd. signage is displayed outside of Herbalife Plaza in Torrance, California, Feb. 3, 2014.
Patrick T. Fallon | Bloomberg | Getty Images

Herbalife delivered quarterly earnings and revenue that surpassed analysts' expectations on Tuesday, sending shares higher in after-hours trading.

The company posted fourth-quarter earnings excluding items of $1.28 per share, up from $1 a share in the year-earlier period. Revenue increased to $1.27 billion from $1.06 billion a year ago.

Analysts had expected the company to report fourth-quarter earnings excluding items of $1.25 a share on $1.25 billion in revenue, according to a consensus estimate from Thomson Reuters.

The company gave significantly higher guidance for the full fiscal year, predicting earnings of $5.85 to $6.05, up from earlier estimates of $5.45 to $5.65.

After the earnings announcement, the company's shares rose as much as 4 percent in after-hours trading. (Click here to get the latest quotes.)

Herbalife said its adjusted earnings for the first quarter would come in between $1.25 and $1.29 per share, up from $1.24 and $1.28 per share. Analysts predicted earnings of $1.35 a share for the fiscal first quarter.

Earlier this month, the nutritional supplements company announced that it would increase its share buyback plan by $500 million.

The company also estimated that its profitability for the first fiscal quarter would fall short of analysts' expectations, predicting its adjusted earnings would come in between $1.24 and $1.28 per share.

Analysts predicted earnings of $1.35 a share for the fiscal first quarter.

Herbalife spent most of last year in the spotlight, surging 139 percent in the wake of a dramatic faceoff with billionaire investor William Ackman.

Ackman's Pershing Square Capital Management has a $1.16 billion short bet against Herbalife and is accusing the company of running an illegal pyramid scheme.

Ackman said his firm has yet to make money on the wager but that its short position is larger today than ever before.

Soros Fund Management, one of the hedge fund industry's most closely watched investors, trimmed its stake in Herbalife by 36 percent late last year.

Hebalife shares are down about 13 percent this year.